Catalyst: Q3 Earnings Snapshot

In this article:

CORAL GABLES, Fla. (AP) — CORAL GABLES, Fla. (AP) — Catalyst Pharmaceutical Partners Inc. (CPRX) on Wednesday reported a loss of $30.8 million in its third quarter.

The Coral Gables, Florida-based company said it had a loss of 29 cents per share. Losses, adjusted for one-time gains and costs, came to 24 cents per share.

The specialty drug company posted revenue of $102.7 million in the period, surpassing Street forecasts. Five analysts surveyed by Zacks expected $100.2 million.

Catalyst expects full-year revenue in the range of $390 million to $395 million.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CPRX at https://www.zacks.com/ap/CPRX

Advertisement